Cargando…

AR-V7 in Metastatic Prostate Cancer: A Strategy beyond Redemption

Metastatic prostate cancer is the most common cancer in males and the fifth cause of cancer mortality worldwide. Despite the major progress in this field, leading to the approval of novel anti-androgens, the prognosis is still poor. A significant number of patients acquire an androgen receptor splic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sobhani, Navid, Neeli, Praveen Kumar, D’Angelo, Alberto, Pittacolo, Matteo, Sirico, Marianna, Galli, Ilaria Camilla, Roviello, Giandomenico, Nesi, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197232/ https://www.ncbi.nlm.nih.gov/pubmed/34073713 http://dx.doi.org/10.3390/ijms22115515

Ejemplares similares

Advances in anti-BRAF therapies for lung cancer
por: Roviello, Giandomenico, et al.
Publicado: (2021)

p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis
por: Sobhani, Navid, et al.
Publicado: (2021)

An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next
por: D’Angelo, Alberto, et al.
Publicado: (2022)

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2019)

Immune checkpoint inhibitor induced nephrotoxicity: An ongoing challenge
por: Catalano, Martina, et al.
Publicado: (2022)

Immune combinations and complete response: a new hope for metastatic renal cell carcinoma
por: Catalano, Martina, et al.
Publicado: (2022)

The combination of bevacizumab with chemotherapy is more beneficial in the metastatic setting rather than in the adjuvant setting for the treatment of HER2-negative breast cancer—a commentary on the E5103 randomized phase III clinical study
por: Roviello, Giandomenico, et al.
Publicado: (2019)

Redemption
Publicado: (1890)

Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials
por: Sobhani, Navid, et al.
Publicado: (2022)

Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments
por: Roviello, Giandomenico, et al.
Publicado: (2022)

PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy
por: Sobhani, Navid, et al.
Publicado: (2017)

Circulating cell-free nucleic acids as prognostic and therapy predictive tools for metastatic castrate-resistant prostate cancer
por: Sobhani, Navid, et al.
Publicado: (2020)

Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?
por: Roviello, Giandomenico, et al.
Publicado: (2020)

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer
por: Sobhani, Navid, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives
por: Roviello, Giandomenico, et al.
Publicado: (2021)

Novel Agents in Heavily Pretreated Metastatic Gastric Cancer: More Shadows Than Lights
por: Roviello, Giandomenico, et al.
Publicado: (2019)

The psychological meaning of redemption motifs in fairytales /
por: Franz, Marie-Luise von, 1915-1998
Publicado: (1980)

MENTAL HEALTH PROGRAMME : NEED FOR REDEMPTION
por: Agarwal, A.K.
Publicado: (1991)

The Redemption of Noise: Inference with Neural Populations
por: Echeveste, Rodrigo, et al.
Publicado: (2018)

Clonal redemption of B cells in cancer
por: McCaw, Tyler R., et al.
Publicado: (2023)

Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter?
por: Roviello, Giandomenico, et al.
Publicado: (2019)

Focus on ROS1-Positive Non-Small Cell Lung Cancer (NSCLC): Crizotinib, Resistance Mechanisms and the Newer Generation of Targeted Therapies
por: D’Angelo, Alberto, et al.
Publicado: (2020)

Inflammation in Urological Malignancies: The Silent Killer
por: Catalano, Martina, et al.
Publicado: (2023)

Networked Religion: Metaphysical Redemption or Eternal Regret?
por: McLaren, Peter
Publicado: (2020)

Comparison of DNA vaccines with AS03 as an adjuvant and an mRNA vaccine against SARS-CoV-2
por: Neeli, Praveen, et al.
Publicado: (2023)

Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma
por: D’Angelo, Alberto, et al.
Publicado: (2019)

REDEMPTION: reduced dimension ensemble modeling and parameter estimation
por: Liu, Yang, et al.
Publicado: (2015)

Les Miserables: Sometimes the Journey to Redemption Has Consequences
por: Johar, Sofian
Publicado: (2019)

C1QBP regulates mitochondrial plasticity to impact tumor progression and antitumor immune response
por: Wang, Qiping, et al.
Publicado: (2022)

Adjuvant Therapy for Renal Cell Carcinoma: Hype or Hope?
por: Cosso, Federica, et al.
Publicado: (2023)

DNA repair deficiency as circulating biomarker in prostate cancer
por: Catalano, Martina, et al.
Publicado: (2023)

Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet‐Uro 19BEYOND study
por: Roviello, Giandomenico, et al.
Publicado: (2022)

Gender and Advanced Urothelial Cancer: Outcome, Efficacy and Toxicity following Chemotherapy
por: Becattini, Lucrezia, et al.
Publicado: (2022)

Risk, Resource, Redemption? The Parenting and Custodial Experiences of Young Offender Fathers
por: Ladlow, Linzi, et al.
Publicado: (2016)

Recalling Memories of Life’s Challenges with Purpose and Redemption: Resources to Foster Resilience?
por: Sharma, Shubam, et al.
Publicado: (2021)

MSI and EBV Positive Gastric Cancer’s Subgroups and Their Link with Novel Immunotherapy
por: Rodriquenz, Maria Grazia, et al.
Publicado: (2020)

Second line of treatment for HER2-positive gastric cancer: an evolving issue
por: Roviello, Giandomenico, et al.
Publicado: (2021)

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8(+)T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
por: Shi, Xiaoqing, et al.
Publicado: (2023)

Redemptive leadership: offering second chances as a value-added management practice
por: Bucci, Joseph
Publicado: (2016)

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer
por: Roviello, Giandomenico, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3dunqv59f4b4oqcvrcip9s2j5s